Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Johnson & Johnson”

Evaluation of Electronic LogMar Visual Acuity and Contrast Sensitivity in a Population of Contact Lens WearersCompleted
NCT03222037Phase 4Updated Sep 10, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Visual Acuity
United States
Total Hip Arthroplasty (THA) Surgical Techniques Comparing the Direct Anterior Approach to the Posterior ApproachCompleted
NCT01807104NAUpdated Aug 29, 2019
Sponsor: Barrett, William, M.D.
Osteoarthritis of the Hip
United States
Clinical Evaluation of Etafilcon A Contact Lenses Using a Novel Molding ProcessTerminated
NCT03605303NAUpdated Aug 28, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Refractive Error Correction
United States
Contact Lens Insertion and Removal in a Senior Subject DemographicCompleted
NCT03597178NAUpdated Aug 28, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Visual Acuity
United States
Pharmacogenetic Clinical Trial of Nepicastat for Post Traumatic Stress Disorder (PTSD)Withdrawn
NCT00641511Phase 2Updated Aug 21, 2019
Sponsor: Michael E. DeBakey VA Medical Center
Post Traumatic Stress Disorder (PTSD)
United States
Evaluation of Two Regimens, With Healthy Male and Female Babies, Ages 3-6 Months Old, Using Various Assessments.Completed
NCT03457857NAUpdated Aug 20, 2019
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Microbiome
United States
Challenge! Adolescent Obesity PreventionCompleted
NCT03103269NAUpdated Aug 16, 2019
Sponsor: University of Maryland, Baltimore
Overweight · Obesity
United States
Patient Priorities Care (PPC)Completed
NCT03600389NAUpdated Jul 5, 2019
Sponsor: Yale University
Multiple Chronic Conditions
Clinical Evaluation of Two Marketed Artificial Tears in Non-contact Lens Wearing PatientsCompleted
NCT03466086Phase 4Updated Jun 28, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Visual Acuity
United Kingdom
Study of Medication for Nonallergic Rhinitis (NAR) Based on Cluster AnalysisUnknown
NCT04002349NAUpdated Jun 28, 2019
Sponsor: Beijing Tongren Hospital
Determination of the Efficacy of Different Medications for Idiopathic Rhinitis · Impact of Different Medications on Biomarkers of Idiopathic Rhinitis · Safety and Tolerance of Different Medications for Idiopathic Rhinitis
China
Drug-drug Interaction Study to Evaluate the Effect of Omeprazole on CG5503 (Tapentadol)Completed
NCT03979989Phase 1Updated Jun 10, 2019
Sponsor: Grünenthal GmbH
Pharmacokinetic
Belgium
Contact Lenses With New UV-blocker Manufactured With Different TechniquesCompleted
NCT03475875Phase 2, Phase 3Updated Jun 4, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Correction of Refraction Error · Attenuation of Bright Light
United States
Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common ColdTerminated
NCT03339726Phase 2Updated Jun 4, 2019
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Common Cold
Canada
Evaluation of Changes to Skin Microbiome With Tape-Stripped WoundsCompleted
NCT03365934NAUpdated Jun 4, 2019
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Healthy Volunteers
United States
Postpartum Weight RetentionCompleted
NCT02867631NAUpdated May 30, 2019
Sponsor: University of Pennsylvania
Obesity · Hypertension · Depression
United States
Identification and Treatment of DepressionCompleted
NCT00863200N/AUpdated May 28, 2019
Sponsor: M.D. Anderson Cancer Center
Cancer
United States
Repeat Insult Patch Test APPENDIX I to HRL Standard Protocol #100Completed
NCT03450070NAUpdated May 15, 2019
Sponsor: Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc.
Allergic Sensitization
United States
Early DHA Supplementation in Very Low Birth Weight InfantsCompleted
NCT03192839NAUpdated May 7, 2019
Sponsor: Mead Johnson Nutrition
Prematurity
United States
Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCLUnknown
NCT02747732Phase 2Updated Apr 23, 2019
Sponsor: Meirav Kedmi MD
Diffuse Large B Cell Lymphoma · Primary Mediastinal (Thymic) Large B-cell Lymphoma · Transformed Indolent Lymphoma · Recurrent Disease
Israel
Increasing Infant Preventive Health Service Delivery in an Inner City PopulationTerminated
NCT00221507NAUpdated Apr 17, 2019
Sponsor: University of Colorado, Denver
Healthy
United States
Paliperidone ER(Invega®) on Depressive Symptoms of Schizophrenia PatientsCompleted
NCT01399450Phase 4Updated Apr 9, 2019
Sponsor: Seoul National University Hospital
Schizophrenia
South Korea
Pediatric Microbiome Study With Children Now Approximately 8-10 Years Old.Completed
NCT03485755N/AUpdated Mar 26, 2019
Sponsor: Johnson & Johnson Consumer Inc. (J&JCI)
Healthy Volunteers
United States
Laparoscopic Approach to Cancer of the EndometriumCompleted
NCT00096408Phase 3Updated Mar 20, 2019
Sponsor: Queensland Centre for Gynaecological Cancer
Endometrial Cancer
Australia, Hong Kong, New Zealand, United Kingdom
A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or PneumoniaCompleted
NCT00515034Phase 2Updated Mar 19, 2019
Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Pneumonia, Ventilator-Associated · Pneumonia, Bacterial · Pneumonia · Abdominal Abscess
Clinical Evaluation of 2-Week Reusable ACUVUE 2 Vivid StyleCompleted
NCT03431441NAUpdated Mar 5, 2019
Sponsor: Johnson & Johnson Vision Care, Inc.
Visual Acuity
United States

Previous page Next page